Aurelia Bank
Credit Risk Console
Overview
Watchlist
Stress testing
Reporting date 31 Mar 2026
Quarter 2026-Q1
All amounts in EUR unless stated
Overview
Healthcare
Healthcare
3 obligors in the wholesale book
Share
Exposure at default
Exposure at default
€284.9m
Committed limit
€310.5m
Drawn
€273.2m
Undrawn
€37.3m
Expected loss
€2.3m
Risk-weighted assets
€314.8m
Weighted average PD
1.78%
Weighted average LGD
40.9%
Facilities
6
Counterparties
3 obligors in the wholesale book
Counterparty
Country
Rating
PD
LGD
EAD
Expected loss
RWA
Utilisation
Corvina Pharma SA
Spain
3.46%
46%
€106.8m
€1.7m
€185.5m
85%
Medistar Clinics Ltd
United Kingdom
1.22%
42%
€103.2m
€527k
€102.7m
92%
Silvan Care Holdings
Germany
0.15%
32%
€74.8m
€36.6k
€26.7m
87%
Corvina Pharma SA
Spain
3.46%
46%
€106.8m
€1.7m
€185.5m
85%
Medistar Clinics Ltd
United Kingdom
1.22%
42%
€103.2m
€527k
€102.7m
92%
Silvan Care Holdings
Germany
0.15%
32%
€74.8m
€36.6k
€26.7m
87%